account_balance
Investment manager · 13F filer · SEC CIK 1617201
Prosight Management, LP
Reported value$580Mas of Jun 30, 2026
Positions36 5 new, 15 sold out
Top 10 weight70.7%LKFT alone is 11%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
LKFTLakefront Biotherapeutics NV
10.6%Added +32%
JANXJanux Therapeutics Inc
10.1%Added +7%
NKTRNektar Therapeutics
9.7%Added +10%
BSXBoston Scientific Corp
9.3%Added +60%
STTKShattuck Labs Inc
7.1%Added +19%
INSMInsmed Inc
6.9%New
ALNYAlnylam Pharmaceuticals Inc
5.1%Added +29%
SNDXSyndax Pharmaceuticals Inc
4.5%Added +56%
KURAKura Oncology Inc
3.8%Trimmed −40%
ALKSAlkermes PLC
3.6%Trimmed −23%
IRTCIrhythm Holdings Inc
3.4%Added +1555%
VEEVVeeva Sys Inc
3.2%Added +23%
LKFTLakefront Biotherapeutics NV
10.6%Added +32%
JANXJanux Therapeutics Inc
10.1%Added +7%
NKTR9.7%BSX9.3%STTK7.1%INSM6.9%ALNY5.1%SNDX4.5%KURA3.8%ALKS3.6%IRTC3.4%VEEV3.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
LKFT Lakefront Biotherapeutics NV 10.6% Added +32%JANX Janux Therapeutics Inc 10.1% Added +7%NKTR Nektar Therapeutics 9.7% Added +10%BSX Boston Scientific Corp 9.3% Added +60%STTK Shattuck Labs Inc 7.1% Added +19%INSM Insmed Inc 6.9% NewALNY Alnylam Pharmaceuticals Inc 5.1% Added +29%SNDX Syndax Pharmaceuticals Inc 4.5% Added +56%KURA Kura Oncology Inc 3.8% Trimmed −40%ALKS Alkermes PLC 3.6% Trimmed −23%IRTC Irhythm Holdings Inc 3.4% Added +1555%VEEV Veeva Sys Inc 3.2% Added +23%
What changed